Impairment of Ubiquitin–Proteasome System by E334K cMyBPC Modifies Channel Proteins, Leading to Electrophysiological Dysfunction-Reference-Cited by-同舟云学术

Impairment of Ubiquitin–Proteasome System by E334K cMyBPC Modifies Channel Proteins, Leading to Electrophysiological Dysfunction

Published:2011-11 Issue:4 Volume:413 Page:857-878
ISSN:0022-2836
Container-title:Journal of Molecular Biology
language:en
Short-container-title:Journal of Molecular Biology

Author:

Bahrudin Udin,Morikawa Kumi,Takeuchi Ayako,Kurata Yasutaka,Miake Junichiro,Mizuta Einosuke,Adachi Kaori,Higaki Katsumi,Yamamoto Yasutaka,Shirayoshi Yasuaki,Yoshida Akio,Kato Masahiko,Yamamoto Kazuhiro,Nanba Eiji,Morisaki Hiroko,Morisaki Takayuki,Matsuoka Satoshi,Ninomiya Haruaki,Hisatome Ichiro

Publisher

Elsevier BV

Subject

Molecular Biology,Structural Biology

Reference52 articles.

1. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms;Seidman;Cell,2001

2. Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland;Jääskeläinen;J. Mol. Med.,2002

3. Cardiac myosin binding protein C;Winegrad;Circ. Res.,1999

4. Changes in cardiac contractility related to calcium-mediated changes in phosphorylation of myosin-binding protein C;McClellan;Biophys. J.,2001

5. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy;Bonne;Nat. Genet.,1995

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genome-wide analysis identifies novel susceptibility loci for heart failure and nonischemic cardiomyopathy subtype;2024-08-02

2. Comprehensive review of indicators and techniques for optical mapping of intracellular calcium ions;Cerebral Cortex;2024-08-01

3. Prospects for the Use of Cell Cultures in Modeling Myocardial Diseases: Hypertrophic Cardiomyopathy;Cell and Tissue Biology;2024-08

4. Arrhythmias and Hypertrophic Cardiomyopathy: Unravelling the Connection;Current Cardiology Reviews;2024-07

5. Azelnidipine protects HL-1 cardiomyocytes from hypoxia/reoxygenation injury by enhancement of NO production independently of effects on gene expression;Heart and Vessels;2024-05-26